Hematologic Malignancies

Surviving CLL: Higher risk of other cancer DXs

February 17, 2023

Despite limits, COVID vaccines protect CLL patients

February 6, 2023

FDA approves pirtobrutinib for r/r mantle cell lymphoma

January 30, 2023

Mastocytosis: Rare, underdiagnosed, potentially fatal

January 24, 2023

Adding venetoclax improves ibrutinib outcomes in CLL

January 23, 2023

Off their pricey CML meds, many thrive

January 20, 2023

Hematologic Malignancies

Multiple myeloma diagnosed more via emergency care during COVID

December 19, 2022

High cost and demand for old cancer drug sparks crisis

December 5, 2022

Hematologic Malignancies

Pandemic caused treatment delay for half of patients with CTCL, study finds

December 2, 2022

Blenrep for multiple myeloma withdrawn from U.S. market

November 22, 2022

CAR T-cell therapy neurotoxicity linked to NfL elevations

October 3, 2022

Drug combo holds promise of better AML outcomes

September 30, 2022

From B to T: a Case of Concurrent B-Cell and T-Cell Lymphomas Successfully Palliated With Targeted Therapies

September 9, 2022

Hematologic Malignancies

Impact of Pharmacist-Driven Telemedicine Services in Hematopoietic Stem Cell Transplant (HSCT) Long-term Care Clinic in a Veteran Population

September 2, 2022

Hematologic Malignancies

Evaluating the Incidence of Febrile Neutropenia and the Appropriate Use of Prophylactic Granulocyte Colony Stimulating Factors in Veterans Who Received Treatment for Non- Hodgkin’s Lymphoma

September 2, 2022

Hematologic Malignancies